nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Hydroxyurea—psoriasis	0.121	0.162	CbGbCtD
Dihydrocodeine—CYP3A4—Calcitriol—psoriasis	0.0905	0.121	CbGbCtD
Dihydrocodeine—CYP2D6—Cholecalciferol—psoriasis	0.0733	0.0981	CbGbCtD
Dihydrocodeine—CYP3A4—Methoxsalen—psoriasis	0.0704	0.0942	CbGbCtD
Dihydrocodeine—CYP2D6—Cyclosporine—psoriasis	0.0482	0.0645	CbGbCtD
Dihydrocodeine—CYP3A4—Cholecalciferol—psoriasis	0.0466	0.0624	CbGbCtD
Dihydrocodeine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0404	0.0541	CbGbCtD
Dihydrocodeine—CYP3A4—Triamcinolone—psoriasis	0.0404	0.0541	CbGbCtD
Dihydrocodeine—CYP3A4—Betamethasone—psoriasis	0.0347	0.0464	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisolone—psoriasis	0.0342	0.0458	CbGbCtD
Dihydrocodeine—CYP3A4—Hydrocortisone—psoriasis	0.0324	0.0434	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—psoriasis	0.0323	0.0433	CbGbCtD
Dihydrocodeine—CYP2D6—Dexamethasone—psoriasis	0.0317	0.0425	CbGbCtD
Dihydrocodeine—CYP3A4—Cyclosporine—psoriasis	0.0306	0.041	CbGbCtD
Dihydrocodeine—CYP3A4—Dexamethasone—psoriasis	0.0202	0.027	CbGbCtD
Dihydrocodeine—Hallucination—Hydrocortisone—psoriasis	0.000692	0.00273	CcSEcCtD
Dihydrocodeine—Dizziness—Acitretin—psoriasis	0.000691	0.00273	CcSEcCtD
Dihydrocodeine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000689	0.00272	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000688	0.00272	CcSEcCtD
Dihydrocodeine—Mental disorder—Cyclosporine—psoriasis	0.000686	0.00271	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Hydroxyurea—psoriasis	0.000676	0.00267	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Mycophenolic acid—psoriasis	0.000674	0.00266	CcSEcCtD
Dihydrocodeine—Mental disorder—Mycophenolate mofetil—psoriasis	0.000669	0.00264	CcSEcCtD
Dihydrocodeine—Skin disorder—Mycophenolic acid—psoriasis	0.000667	0.00264	CcSEcCtD
Dihydrocodeine—Vomiting—Acitretin—psoriasis	0.000664	0.00263	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.000664	0.00262	CcSEcCtD
Dihydrocodeine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000663	0.00262	CcSEcCtD
Dihydrocodeine—Rash—Acitretin—psoriasis	0.000659	0.0026	CcSEcCtD
Dihydrocodeine—Dermatitis—Acitretin—psoriasis	0.000658	0.0026	CcSEcCtD
Dihydrocodeine—Rash—Fluocinolone Acetonide—psoriasis	0.000657	0.0026	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000656	0.00259	CcSEcCtD
Dihydrocodeine—Headache—Acitretin—psoriasis	0.000655	0.00259	CcSEcCtD
Dihydrocodeine—Headache—Fluocinolone Acetonide—psoriasis	0.000653	0.00258	CcSEcCtD
Dihydrocodeine—Hypotension—Mycophenolic acid—psoriasis	0.000642	0.00254	CcSEcCtD
Dihydrocodeine—Immune system disorder—Hydrocortisone—psoriasis	0.000628	0.00248	CcSEcCtD
Dihydrocodeine—Angioedema—Cyclosporine—psoriasis	0.000622	0.00246	CcSEcCtD
Dihydrocodeine—Nausea—Acitretin—psoriasis	0.000621	0.00245	CcSEcCtD
Dihydrocodeine—Nausea—Fluocinolone Acetonide—psoriasis	0.000619	0.00245	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mycophenolic acid—psoriasis	0.000617	0.00244	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mycophenolic acid—psoriasis	0.000613	0.00242	CcSEcCtD
Dihydrocodeine—Vertigo—Cyclosporine—psoriasis	0.000612	0.00242	CcSEcCtD
Dihydrocodeine—Somnolence—Mycophenolic acid—psoriasis	0.000611	0.00241	CcSEcCtD
Dihydrocodeine—Mental disorder—Hydrocortisone—psoriasis	0.000609	0.00241	CcSEcCtD
Dihydrocodeine—Angioedema—Mycophenolate mofetil—psoriasis	0.000607	0.0024	CcSEcCtD
Dihydrocodeine—Vertigo—Mycophenolate mofetil—psoriasis	0.000597	0.00236	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000593	0.00234	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—psoriasis	0.000592	0.00234	CcSEcCtD
Dihydrocodeine—Hallucination—Betamethasone—psoriasis	0.000591	0.00234	CcSEcCtD
Dihydrocodeine—Hallucination—Dexamethasone—psoriasis	0.000591	0.00234	CcSEcCtD
Dihydrocodeine—Convulsion—Cyclosporine—psoriasis	0.00059	0.00233	CcSEcCtD
Dihydrocodeine—Constipation—Mycophenolic acid—psoriasis	0.000588	0.00232	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000576	0.00228	CcSEcCtD
Dihydrocodeine—Convulsion—Mycophenolate mofetil—psoriasis	0.000576	0.00227	CcSEcCtD
Dihydrocodeine—Dry mouth—Cyclosporine—psoriasis	0.000567	0.00224	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisolone—psoriasis	0.000566	0.00224	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000566	0.00224	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000562	0.00222	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000562	0.00222	CcSEcCtD
Dihydrocodeine—Diarrhoea—Hydroxyurea—psoriasis	0.000561	0.00222	CcSEcCtD
Dihydrocodeine—Confusional state—Cyclosporine—psoriasis	0.000561	0.00221	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisolone—psoriasis	0.000557	0.0022	CcSEcCtD
Dihydrocodeine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000553	0.00219	CcSEcCtD
Dihydrocodeine—Angioedema—Hydrocortisone—psoriasis	0.000553	0.00219	CcSEcCtD
Dihydrocodeine—Confusional state—Mycophenolate mofetil—psoriasis	0.000547	0.00216	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Cyclosporine—psoriasis	0.000545	0.00215	CcSEcCtD
Dihydrocodeine—Vertigo—Hydrocortisone—psoriasis	0.000544	0.00215	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mycophenolic acid—psoriasis	0.000543	0.00215	CcSEcCtD
Dihydrocodeine—Dizziness—Hydroxyurea—psoriasis	0.000543	0.00214	CcSEcCtD
Dihydrocodeine—Skin disorder—Cyclosporine—psoriasis	0.00054	0.00213	CcSEcCtD
Dihydrocodeine—Angiopathy—Dexamethasone—psoriasis	0.000539	0.00213	CcSEcCtD
Dihydrocodeine—Angiopathy—Betamethasone—psoriasis	0.000539	0.00213	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Cyclosporine—psoriasis	0.000537	0.00212	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisolone—psoriasis	0.000537	0.00212	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000532	0.0021	CcSEcCtD
Dihydrocodeine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000527	0.00208	CcSEcCtD
Dihydrocodeine—Convulsion—Hydrocortisone—psoriasis	0.000525	0.00207	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000524	0.00207	CcSEcCtD
Dihydrocodeine—Vomiting—Hydroxyurea—psoriasis	0.000522	0.00206	CcSEcCtD
Dihydrocodeine—Angioedema—Triamcinolone—psoriasis	0.000521	0.00206	CcSEcCtD
Dihydrocodeine—Rash—Hydroxyurea—psoriasis	0.000517	0.00204	CcSEcCtD
Dihydrocodeine—Dermatitis—Hydroxyurea—psoriasis	0.000517	0.00204	CcSEcCtD
Dihydrocodeine—Hallucination—Prednisone—psoriasis	0.000515	0.00203	CcSEcCtD
Dihydrocodeine—Headache—Hydroxyurea—psoriasis	0.000514	0.00203	CcSEcCtD
Dihydrocodeine—Vertigo—Triamcinolone—psoriasis	0.000512	0.00202	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000512	0.00202	CcSEcCtD
Dihydrocodeine—Hypotension—Mycophenolate mofetil—psoriasis	0.000507	0.002	CcSEcCtD
Dihydrocodeine—Paraesthesia—Cyclosporine—psoriasis	0.000499	0.00197	CcSEcCtD
Dihydrocodeine—Dyspnoea—Cyclosporine—psoriasis	0.000496	0.00196	CcSEcCtD
Dihydrocodeine—Somnolence—Cyclosporine—psoriasis	0.000494	0.00195	CcSEcCtD
Dihydrocodeine—Convulsion—Triamcinolone—psoriasis	0.000494	0.00195	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisolone—psoriasis	0.000489	0.00193	CcSEcCtD
Dihydrocodeine—Nausea—Hydroxyurea—psoriasis	0.000487	0.00193	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000487	0.00192	CcSEcCtD
Dihydrocodeine—Pruritus—Mycophenolic acid—psoriasis	0.000486	0.00192	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Hydrocortisone—psoriasis	0.000485	0.00191	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000483	0.00191	CcSEcCtD
Dihydrocodeine—Somnolence—Mycophenolate mofetil—psoriasis	0.000482	0.0019	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00048	0.0019	CcSEcCtD
Dihydrocodeine—Skin disorder—Hydrocortisone—psoriasis	0.00048	0.0019	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000478	0.00189	CcSEcCtD
Dihydrocodeine—Constipation—Cyclosporine—psoriasis	0.000475	0.00188	CcSEcCtD
Dihydrocodeine—Dry mouth—Triamcinolone—psoriasis	0.000475	0.00188	CcSEcCtD
Dihydrocodeine—Angioedema—Dexamethasone—psoriasis	0.000473	0.00187	CcSEcCtD
Dihydrocodeine—Angioedema—Betamethasone—psoriasis	0.000473	0.00187	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mycophenolic acid—psoriasis	0.00047	0.00186	CcSEcCtD
Dihydrocodeine—Angiopathy—Prednisone—psoriasis	0.000469	0.00185	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000468	0.00185	CcSEcCtD
Dihydrocodeine—Immune system disorder—Prednisone—psoriasis	0.000467	0.00185	CcSEcCtD
Dihydrocodeine—Vertigo—Dexamethasone—psoriasis	0.000465	0.00184	CcSEcCtD
Dihydrocodeine—Vertigo—Betamethasone—psoriasis	0.000465	0.00184	CcSEcCtD
Dihydrocodeine—Constipation—Mycophenolate mofetil—psoriasis	0.000464	0.00183	CcSEcCtD
Dihydrocodeine—Hypotension—Hydrocortisone—psoriasis	0.000462	0.00182	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Cyclosporine—psoriasis	0.000458	0.00181	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—psoriasis	0.000456	0.0018	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000455	0.0018	CcSEcCtD
Dihydrocodeine—Dizziness—Mycophenolic acid—psoriasis	0.000454	0.0018	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisolone—psoriasis	0.000454	0.00179	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—psoriasis	0.000453	0.00179	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Triamcinolone—psoriasis	0.00045	0.00178	CcSEcCtD
Dihydrocodeine—Convulsion—Betamethasone—psoriasis	0.000448	0.00177	CcSEcCtD
Dihydrocodeine—Convulsion—Dexamethasone—psoriasis	0.000448	0.00177	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000447	0.00177	CcSEcCtD
Dihydrocodeine—Paraesthesia—Hydrocortisone—psoriasis	0.000444	0.00175	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000443	0.00175	CcSEcCtD
Dihydrocodeine—Urticaria—Cyclosporine—psoriasis	0.000442	0.00174	CcSEcCtD
Dihydrocodeine—Abdominal pain—Cyclosporine—psoriasis	0.000439	0.00174	CcSEcCtD
Dihydrocodeine—Vomiting—Mycophenolic acid—psoriasis	0.000437	0.00173	CcSEcCtD
Dihydrocodeine—Rash—Mycophenolic acid—psoriasis	0.000433	0.00171	CcSEcCtD
Dihydrocodeine—Dermatitis—Mycophenolic acid—psoriasis	0.000433	0.00171	CcSEcCtD
Dihydrocodeine—Urticaria—Mycophenolate mofetil—psoriasis	0.000431	0.0017	CcSEcCtD
Dihydrocodeine—Headache—Mycophenolic acid—psoriasis	0.00043	0.0017	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000429	0.00169	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—psoriasis	0.000427	0.00169	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000427	0.00169	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—psoriasis	0.000424	0.00167	CcSEcCtD
Dihydrocodeine—Paraesthesia—Triamcinolone—psoriasis	0.000418	0.00165	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisolone—psoriasis	0.000417	0.00165	CcSEcCtD
Dihydrocodeine—Dyspnoea—Triamcinolone—psoriasis	0.000415	0.00164	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Betamethasone—psoriasis	0.000414	0.00164	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Dexamethasone—psoriasis	0.000414	0.00164	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—psoriasis	0.000412	0.00163	CcSEcCtD
Dihydrocodeine—Nausea—Mycophenolic acid—psoriasis	0.000408	0.00161	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Betamethasone—psoriasis	0.000408	0.00161	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Dexamethasone—psoriasis	0.000408	0.00161	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Hydrocortisone—psoriasis	0.000407	0.00161	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—psoriasis	0.000405	0.0016	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000404	0.0016	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisolone—psoriasis	0.000402	0.00159	CcSEcCtD
Dihydrocodeine—Hypotension—Dexamethasone—psoriasis	0.000394	0.00156	CcSEcCtD
Dihydrocodeine—Hypotension—Betamethasone—psoriasis	0.000394	0.00156	CcSEcCtD
Dihydrocodeine—Pruritus—Cyclosporine—psoriasis	0.000393	0.00155	CcSEcCtD
Dihydrocodeine—Urticaria—Hydrocortisone—psoriasis	0.000392	0.00155	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—psoriasis	0.000392	0.00155	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—psoriasis	0.000391	0.00154	CcSEcCtD
Dihydrocodeine—Abdominal pain—Hydrocortisone—psoriasis	0.000391	0.00154	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisone—psoriasis	0.00039	0.00154	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—psoriasis	0.00039	0.00154	CcSEcCtD
Dihydrocodeine—Pruritus—Mycophenolate mofetil—psoriasis	0.000384	0.00152	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Triamcinolone—psoriasis	0.000383	0.00151	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000381	0.0015	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cyclosporine—psoriasis	0.00038	0.0015	CcSEcCtD
Dihydrocodeine—Paraesthesia—Betamethasone—psoriasis	0.000379	0.0015	CcSEcCtD
Dihydrocodeine—Paraesthesia—Dexamethasone—psoriasis	0.000379	0.0015	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—psoriasis	0.000379	0.0015	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000371	0.00147	CcSEcCtD
Dihydrocodeine—Urticaria—Triamcinolone—psoriasis	0.00037	0.00146	CcSEcCtD
Dihydrocodeine—Dizziness—Cyclosporine—psoriasis	0.000368	0.00145	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000364	0.00144	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000364	0.00144	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Prednisone—psoriasis	0.000361	0.00142	CcSEcCtD
Dihydrocodeine—Dizziness—Mycophenolate mofetil—psoriasis	0.000359	0.00142	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—psoriasis	0.000357	0.00141	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisone—psoriasis	0.000355	0.0014	CcSEcCtD
Dihydrocodeine—Vomiting—Cyclosporine—psoriasis	0.000353	0.0014	CcSEcCtD
Dihydrocodeine—Rash—Cyclosporine—psoriasis	0.000351	0.00138	CcSEcCtD
Dihydrocodeine—Dermatitis—Cyclosporine—psoriasis	0.00035	0.00138	CcSEcCtD
Dihydrocodeine—Pruritus—Hydrocortisone—psoriasis	0.00035	0.00138	CcSEcCtD
Dihydrocodeine—Headache—Cyclosporine—psoriasis	0.000348	0.00138	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Betamethasone—psoriasis	0.000348	0.00137	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dexamethasone—psoriasis	0.000348	0.00137	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Betamethasone—psoriasis	0.000345	0.00136	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000345	0.00136	CcSEcCtD
Dihydrocodeine—Vomiting—Mycophenolate mofetil—psoriasis	0.000345	0.00136	CcSEcCtD
Dihydrocodeine—Rash—Mycophenolate mofetil—psoriasis	0.000342	0.00135	CcSEcCtD
Dihydrocodeine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000342	0.00135	CcSEcCtD
Dihydrocodeine—Headache—Mycophenolate mofetil—psoriasis	0.00034	0.00134	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—psoriasis	0.000338	0.00134	CcSEcCtD
Dihydrocodeine—Diarrhoea—Hydrocortisone—psoriasis	0.000338	0.00134	CcSEcCtD
Dihydrocodeine—Urticaria—Betamethasone—psoriasis	0.000335	0.00132	CcSEcCtD
Dihydrocodeine—Urticaria—Dexamethasone—psoriasis	0.000335	0.00132	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisolone—psoriasis	0.000335	0.00132	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dexamethasone—psoriasis	0.000334	0.00132	CcSEcCtD
Dihydrocodeine—Abdominal pain—Betamethasone—psoriasis	0.000334	0.00132	CcSEcCtD
Dihydrocodeine—Nausea—Cyclosporine—psoriasis	0.00033	0.0013	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—psoriasis	0.00033	0.0013	CcSEcCtD
Dihydrocodeine—Pruritus—Triamcinolone—psoriasis	0.000329	0.0013	CcSEcCtD
Dihydrocodeine—Dizziness—Hydrocortisone—psoriasis	0.000327	0.00129	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—psoriasis	0.000326	0.00129	CcSEcCtD
Dihydrocodeine—Nausea—Mycophenolate mofetil—psoriasis	0.000322	0.00127	CcSEcCtD
Dihydrocodeine—Rash—Prednisolone—psoriasis	0.000319	0.00126	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisolone—psoriasis	0.000319	0.00126	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000318	0.00126	CcSEcCtD
Dihydrocodeine—Headache—Prednisolone—psoriasis	0.000317	0.00125	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—psoriasis	0.000314	0.00124	CcSEcCtD
Dihydrocodeine—Vomiting—Hydrocortisone—psoriasis	0.000314	0.00124	CcSEcCtD
Dihydrocodeine—Rash—Hydrocortisone—psoriasis	0.000312	0.00123	CcSEcCtD
Dihydrocodeine—Dermatitis—Hydrocortisone—psoriasis	0.000311	0.00123	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—psoriasis	0.00031	0.00122	CcSEcCtD
Dihydrocodeine—Headache—Hydrocortisone—psoriasis	0.00031	0.00122	CcSEcCtD
Dihydrocodeine—Dizziness—Triamcinolone—psoriasis	0.000308	0.00122	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisone—psoriasis	0.000303	0.0012	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—psoriasis	0.000301	0.00119	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—psoriasis	0.000301	0.00119	CcSEcCtD
Dihydrocodeine—Nausea—Prednisolone—psoriasis	0.0003	0.00119	CcSEcCtD
Dihydrocodeine—Pruritus—Betamethasone—psoriasis	0.000299	0.00118	CcSEcCtD
Dihydrocodeine—Pruritus—Dexamethasone—psoriasis	0.000299	0.00118	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—psoriasis	0.000298	0.00118	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—psoriasis	0.000297	0.00117	CcSEcCtD
Dihydrocodeine—Vomiting—Triamcinolone—psoriasis	0.000296	0.00117	CcSEcCtD
Dihydrocodeine—Nausea—Hydrocortisone—psoriasis	0.000293	0.00116	CcSEcCtD
Dihydrocodeine—Rash—Triamcinolone—psoriasis	0.000293	0.00116	CcSEcCtD
Dihydrocodeine—Dermatitis—Triamcinolone—psoriasis	0.000293	0.00116	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisone—psoriasis	0.000292	0.00115	CcSEcCtD
Dihydrocodeine—Headache—Triamcinolone—psoriasis	0.000291	0.00115	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—psoriasis	0.000291	0.00115	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dexamethasone—psoriasis	0.000289	0.00114	CcSEcCtD
Dihydrocodeine—Diarrhoea—Betamethasone—psoriasis	0.000289	0.00114	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—psoriasis	0.000287	0.00113	CcSEcCtD
Dihydrocodeine—Dizziness—Betamethasone—psoriasis	0.000279	0.0011	CcSEcCtD
Dihydrocodeine—Dizziness—Dexamethasone—psoriasis	0.000279	0.0011	CcSEcCtD
Dihydrocodeine—Nausea—Triamcinolone—psoriasis	0.000276	0.00109	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—psoriasis	0.000276	0.00109	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—psoriasis	0.000274	0.00108	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—psoriasis	0.000273	0.00108	CcSEcCtD
Dihydrocodeine—Vomiting—Dexamethasone—psoriasis	0.000268	0.00106	CcSEcCtD
Dihydrocodeine—Vomiting—Betamethasone—psoriasis	0.000268	0.00106	CcSEcCtD
Dihydrocodeine—Rash—Betamethasone—psoriasis	0.000266	0.00105	CcSEcCtD
Dihydrocodeine—Rash—Dexamethasone—psoriasis	0.000266	0.00105	CcSEcCtD
Dihydrocodeine—Dermatitis—Betamethasone—psoriasis	0.000266	0.00105	CcSEcCtD
Dihydrocodeine—Dermatitis—Dexamethasone—psoriasis	0.000266	0.00105	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000265	0.00105	CcSEcCtD
Dihydrocodeine—Headache—Dexamethasone—psoriasis	0.000264	0.00104	CcSEcCtD
Dihydrocodeine—Headache—Betamethasone—psoriasis	0.000264	0.00104	CcSEcCtD
Dihydrocodeine—Pruritus—Prednisone—psoriasis	0.00026	0.00103	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—psoriasis	0.000253	0.001	CcSEcCtD
Dihydrocodeine—Diarrhoea—Prednisone—psoriasis	0.000252	0.000994	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—psoriasis	0.000251	0.000993	CcSEcCtD
Dihydrocodeine—Nausea—Dexamethasone—psoriasis	0.000251	0.000991	CcSEcCtD
Dihydrocodeine—Nausea—Betamethasone—psoriasis	0.000251	0.000991	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—psoriasis	0.000244	0.000964	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisone—psoriasis	0.000243	0.00096	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—psoriasis	0.000243	0.00096	CcSEcCtD
Dihydrocodeine—Vomiting—Prednisone—psoriasis	0.000234	0.000923	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—psoriasis	0.000232	0.000916	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—psoriasis	0.000232	0.000915	CcSEcCtD
Dihydrocodeine—Headache—Prednisone—psoriasis	0.00023	0.00091	CcSEcCtD
Dihydrocodeine—Nausea—Prednisone—psoriasis	0.000218	0.000863	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—psoriasis	0.000217	0.000859	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—psoriasis	0.00021	0.000831	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—psoriasis	0.000203	0.000803	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—psoriasis	0.000195	0.000772	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—psoriasis	0.000194	0.000765	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—psoriasis	0.000194	0.000765	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—psoriasis	0.000192	0.00076	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—psoriasis	0.000182	0.000721	CcSEcCtD
